Effects of Surgical Timing on Perioperative Clinical Outcomes in Pancreaticoduodenectomy
Launched by WEST CHINA HOSPITAL · Mar 9, 2025
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients must be required to sign an informed consent form;
- • 2. Age 18-80 years, male and female;
- • 3. ECOG Physical Status Score (PS Score) 0 or 1.
- • 4. Pancreaticoduodenectomy at our center without contraindications related to the surgery.
- Exclusion Criteria:
- • 1. Pre-existing or concurrent other malignant tumors
- • 2. Severe cardiopulmonary and renal dysfunction.
- • 3. Autoimmune disease or history of immunodeficiency
- • 4. Active infections and infectious diseases requiring systemic therapy.
- • 5. History of psychotropic substance abuse, alcoholism or drug addiction.
- • 6. Failure to meet the inclusion criteria as determined by the investigator.
About West China Hospital
West China Hospital, affiliated with Sichuan University, is a leading medical institution renowned for its comprehensive healthcare services, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, the hospital leverages its extensive resources and expertise to facilitate innovative research in various therapeutic areas. With a focus on improving patient outcomes and advancing medical knowledge, West China Hospital collaborates with various stakeholders to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards. Its state-of-the-art facilities and multidisciplinary teams ensure the successful execution of trials, contributing significantly to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Changzhou, Jiangsu, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported